Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
Public ClinicalTrials.gov record NCT06824818. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Feasibility Trial of LHRH Agonist Discontinuation in Elderly Prostate Cancer Patients
Study identification
- NCT ID
- NCT06824818
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- University of Chicago
- Other
- Enrollment
- 155 participants
Conditions and interventions
Conditions
Interventions
- LHRH Agonist Therapy Discontinuation Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 70 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2026
- Primary completion
- Nov 30, 2026
- Completion
- May 31, 2027
- Last update posted
- Sep 30, 2025
2026 – 2027
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Illinois at Chicago (UIC) | Chicago | Illinois | 60607 | Recruiting |
| UChicago Medicine Comprehensive Cancer Center | Chicago | Illinois | 60637 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06824818, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06824818 live on ClinicalTrials.gov.